| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acute GVHD prophylaxis—atorvastatin for donor and recipient
|
Gilbert, Judith A
|
|
2013
|
14 |
13 |
p. e589-
1 p.
|
artikel
|
| 2 |
Adjuvant treatment for resected pancreatic adenocarcinoma—still an unresolved issue
|
Leung, John
|
|
2013
|
14 |
13 |
p. e583-e584
nvt p.
|
artikel
|
| 3 |
Axitinib in advanced renal-cell carcinoma
|
Yousaf, Nadia
|
|
2013
|
14 |
13 |
p. 1245-1246
2 p.
|
artikel
|
| 4 |
Axitinib versus sorafenib as first-line therapy in patients with metastatic renal-cell carcinoma: a randomised open-label phase 3 trial
|
Hutson, Thomas E
|
|
2013
|
14 |
13 |
p. 1287-1294
8 p.
|
artikel
|
| 5 |
Biomarker for high-risk patients with stage II colon cancer
|
Watanabe, Toshiaki
|
|
2013
|
14 |
13 |
p. 1247-1248
2 p.
|
artikel
|
| 6 |
Brentuximab vedotin combined with ABVD or AVD for patients with newly diagnosed Hodgkin's lymphoma: a phase 1, open-label, dose-escalation study
|
Younes, Anas
|
|
2013
|
14 |
13 |
p. 1348-1356
9 p.
|
artikel
|
| 7 |
Can we improve ABVD in Hodgkin's lymphoma?
|
Gisselbrecht, Christian
|
|
2013
|
14 |
13 |
p. 1254-1256
3 p.
|
artikel
|
| 8 |
Cetuximab and non-small-cell lung cancer: end of the story?
|
Rossi, Antonio
|
|
2013
|
14 |
13 |
p. 1251-1253
3 p.
|
artikel
|
| 9 |
CT screening for lung cancer: countdown to implementation
|
Field, John K
|
|
2013
|
14 |
13 |
p. e591-e600
nvt p.
|
artikel
|
| 10 |
Dasatinib and docetaxel in advanced prostate cancer
|
Lara Jr, Primo N
|
|
2013
|
14 |
13 |
p. 1248-1249
2 p.
|
artikel
|
| 11 |
Diagnostic performance of narrowed spectrum endoscopy, autofluorescence imaging, and confocal laser endomicroscopy for optical diagnosis of colonic polyps: a meta-analysis
|
Wanders, Linda K
|
|
2013
|
14 |
13 |
p. 1337-1347
11 p.
|
artikel
|
| 12 |
Dignity in death: the triumph of politics over evidence
|
The Lancet Oncology,
|
|
2013
|
14 |
13 |
p. 1243-
1 p.
|
artikel
|
| 13 |
Docetaxel and dasatinib or placebo in men with metastatic castration-resistant prostate cancer (READY): a randomised, double-blind phase 3 trial
|
Araujo, John C
|
|
2013
|
14 |
13 |
p. 1307-1316
10 p.
|
artikel
|
| 14 |
Docetaxel or pemetrexed with or without cetuximab in recurrent or progressive non-small-cell lung cancer after platinum-based therapy: a phase 3, open-label, randomised trial
|
Kim, Edward S
|
|
2013
|
14 |
13 |
p. 1326-1336
11 p.
|
artikel
|
| 15 |
Endoscopic optical biopsy: when we look, what can we see?
|
Ladabaum, Uri
|
|
2013
|
14 |
13 |
p. 1253-1254
2 p.
|
artikel
|
| 16 |
Fluorouracil, epirubicin, and cyclophosphamide (FEC-75) followed by paclitaxel plus trastuzumab versus paclitaxel plus trastuzumab followed by FEC-75 plus trastuzumab as neoadjuvant treatment for patients with HER2-positive breast cancer (Z1041): a randomised, controlled, phase 3 trial
|
Buzdar, Aman U
|
|
2013
|
14 |
13 |
p. 1317-1325
9 p.
|
artikel
|
| 17 |
HAND2 methylation linked to endometrial cancer
|
Bagcchi, Sanjeet
|
|
2013
|
14 |
13 |
p. e590-
1 p.
|
artikel
|
| 18 |
Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial
|
Veronesi, Umberto
|
|
2013
|
14 |
13 |
p. 1269-1277
9 p.
|
artikel
|
| 19 |
Leucovorin, fluorouracil, and oxaliplatin plus bevacizumab versus S-1 and oxaliplatin plus bevacizumab in patients with metastatic colorectal cancer (SOFT): an open-label, non-inferiority, randomised phase 3 trial
|
Yamada, Yasuhide
|
|
2013
|
14 |
13 |
p. 1278-1286
9 p.
|
artikel
|
| 20 |
Mistletoe: for cancer or just for Christmas?
|
de Giorgio, Alex
|
|
2013
|
14 |
13 |
p. 1264-1265
2 p.
|
artikel
|
| 21 |
Mondays at Racine
|
van Dorn, Aaron
|
|
2013
|
14 |
13 |
p. 1267-
1 p.
|
artikel
|
| 22 |
Mutations in chondroblastoma and giant cell tumour of bone
|
Yaqub, Farhat
|
|
2013
|
14 |
13 |
p. e587-
1 p.
|
artikel
|
| 23 |
Nab-paclitaxel shows promise in pancreatic cancer
|
Baker, Holly
|
|
2013
|
14 |
13 |
p. e585-
1 p.
|
artikel
|
| 24 |
NCRI Cancer Conference
|
Smith, Lan-Lan
|
|
2013
|
14 |
13 |
p. 1261-
1 p.
|
artikel
|
| 25 |
Neonatal cancer
|
Orbach, Daniel
|
|
2013
|
14 |
13 |
p. e609-e620
nvt p.
|
artikel
|
| 26 |
New immunotherapy on horizon for melanoma?
|
Sharma, Sharan Prakash
|
|
2013
|
14 |
13 |
p. e586-
1 p.
|
artikel
|
| 27 |
No increase in overall cancer risk from assisted conception
|
Baker, Holly
|
|
2013
|
14 |
13 |
p. e589-
1 p.
|
artikel
|
| 28 |
One dose of HPV vaccine may suffice
|
Tanday, Sanjay
|
|
2013
|
14 |
13 |
p. e588-
1 p.
|
artikel
|
| 29 |
Ovarian transposition in prepubescent and adolescent girls with cancer
|
Irtan, Sabine
|
|
2013
|
14 |
13 |
p. e601-e608
nvt p.
|
artikel
|
| 30 |
Perspectives on breast cancer in Arab populations
|
Corbex, Marilys
|
|
2013
|
14 |
13 |
p. e582-
1 p.
|
artikel
|
| 31 |
Ponatinib: hope for patients with CML or Ph-positive ALL?
|
Yaqub, Farhat
|
|
2013
|
14 |
13 |
p. e588-
1 p.
|
artikel
|
| 32 |
Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis
|
Zhang, Jia-Xing
|
|
2013
|
14 |
13 |
p. 1295-1306
12 p.
|
artikel
|
| 33 |
Recommendations for breast cancer surveillance for female survivors of childhood, adolescent, and young adult cancer given chest radiation: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group
|
Mulder, Renée L
|
|
2013
|
14 |
13 |
p. e621-e629
nvt p.
|
artikel
|
| 34 |
Reproducing our species and finding solutions
|
Halperin, Edward C
|
|
2013
|
14 |
13 |
p. 1256-1258
3 p.
|
artikel
|
| 35 |
S-1: another oral agent for patients with colorectal cancer
|
Benson III, Al B
|
|
2013
|
14 |
13 |
p. 1244-1245
2 p.
|
artikel
|
| 36 |
Screw You Cancer
|
Clague, Stephanie
|
|
2013
|
14 |
13 |
p. 1265-1266
2 p.
|
artikel
|
| 37 |
Self-referral for IMRT in prostate cancer treatment
|
Burki, Talha Khan
|
|
2013
|
14 |
13 |
p. e586-
1 p.
|
artikel
|
| 38 |
Should oncologists support the Affordable Care Act?
|
Kantarjian, Hagop
|
|
2013
|
14 |
13 |
p. 1258-1259
2 p.
|
artikel
|
| 39 |
12th AACR Frontiers in Cancer Prevention Research meeting
|
McLarnon, Andy
|
|
2013
|
14 |
13 |
p. e587-
1 p.
|
artikel
|
| 40 |
The beginning after the end
|
Collett, John
|
|
2013
|
14 |
13 |
p. 1267-1268
2 p.
|
artikel
|
| 41 |
The carcinogenicity of outdoor air pollution
|
Loomis, Dana
|
|
2013
|
14 |
13 |
p. 1262-1263
2 p.
|
artikel
|
| 42 |
15th IASLC World Conference on Lung Cancer
|
Brierley, Rob
|
|
2013
|
14 |
13 |
p. 1260-
1 p.
|
artikel
|
| 43 |
Time for evidence-based e-cigarette regulation
|
Polosa, Riccardo
|
|
2013
|
14 |
13 |
p. e582-e583
nvt p.
|
artikel
|
| 44 |
Tongue cancers not associated with tobacco in Chennai
|
Sharma, Dinesh C
|
|
2013
|
14 |
13 |
p. e590-
1 p.
|
artikel
|
| 45 |
Treatment of HER2-positive breast cancer: looking backwards briefly
|
Puhalla, Shannon
|
|
2013
|
14 |
13 |
p. 1250-1251
2 p.
|
artikel
|
| 46 |
Vintafolide combination for ovarian cancer
|
Gilbert, Judith A
|
|
2013
|
14 |
13 |
p. e585-
1 p.
|
artikel
|
| 47 |
Ways to Live Forever
|
Hill, Emma
|
|
2013
|
14 |
13 |
p. 1266-
1 p.
|
artikel
|
Tijdschrift beschrijving